Subcutaneous Leukemia Cutis as the Initial Manifestation of CD23 Negative CLL/SLL in a Patient With Rheumatoid Arthritis on Chronic TNF-Alpha Inhibition. This evidence concerns the gene FCER2 and B-cell chronic lymphocytic leukemia.